Apellis Pharmaceuticals to Present at the BofA Securities 2020 Health Care Conference

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation at the BofA Securities 2020 Health Care Conference on May 14, 2020, at 8:20 a.m. ET. The event will take place virtually, featuring a fireside chat with CEO Cedric Francois. The discussion will be accessible via a live webcast on the company’s Investors and Media page. Following the event, a replay will be available for 90 days. Apellis focuses on developing targeted C3 therapies for diseases caused by excessive complement activation.

WALTHAM, Mass., May 08, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company will present at the BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 8:20 a.m. ET. The conference will be held in a virtual meeting format.

Cedric Francois, M.D., Ph.D., co-founder and chief executive officer of Apellis, will participate in a fireside chat. The event will be available via live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at http://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. By pioneering targeted C3 therapies, we aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.

Investor Contact:
Sam Martin / Maghan Meyers
Argot Partners
sam@argotpartners.com / maghan@argotpartners.com
212.600.1902

FAQ

When will Apellis Pharmaceuticals present at the BofA Securities 2020 Health Care Conference?

Apellis Pharmaceuticals will present on May 14, 2020, at 8:20 a.m. ET.

Who will represent Apellis Pharmaceuticals at the conference?

CEO Cedric Francois will participate in a fireside chat.

How can I watch the Apellis Pharmaceuticals conference presentation?

The presentation will be available via live webcast on the company’s Investors and Media page.

Will there be a replay of the Apellis Pharmaceuticals conference presentation?

Yes, a replay will be available for 90 days after the event.

What is the focus of Apellis Pharmaceuticals?

Apellis Pharmaceuticals is focused on developing targeted C3 therapies for various diseases driven by excessive complement activation.